Actively Recruiting
Gynecologic Extramammary Paget's Disease
Led by Mayo Clinic · Updated on 2026-01-28
100
Participants Needed
1
Research Sites
1710 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
In addition to evaluating treatment outcomes, tissue samples and swabs will be collected as part of this study to allow physicians to better understand Extramammary Paget's Disease (EMPD). The researchers also want to learn more about the microorganisms (microbiome) that live on or near the areas of skin affected by EMPD, in order to better understand this condition.
CONDITIONS
Official Title
Gynecologic Extramammary Paget's Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Females
- Age 18 years or older
- Diagnosed with primary or recurrent EMPD of vulva and/or perianal region of the body
- Willing and able to provide signed informed consent
You will not qualify if you...
- Males
- Diagnosis of Paget's Disease in body areas other than vulvar or perianal region
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Mayo Clinic
Rochester, Minnesota, United States, 55905
Actively Recruiting
Research Team
M
Maureen A. Lemens, R.N.
CONTACT
K
Karen P Ishitani, RN
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here